Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
EV/Core EBITDA

    Back to All Ratios
SHREE GANESH REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 19.5513.8116.3921.084.34

What is the latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES ?

The latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES is 19.55 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202419.55
Mar202313.81
Mar202216.39
Mar202121.08
Mar20204.34

How is EV/Core EBITDA of SHREE GANESH REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 19.55
41.56
Mar2023 13.81
-15.74
Mar2022 16.39
-22.25
Mar2021 21.08
385.71
Mar2020 4.34 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare EV/Core EBITDA ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹879.0 Cr -5.1% 2.4% 1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

-5.1%

2.4%

1%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses